SEARCH   
MEMBER LOGIN    

Veterinary Pharmaceutical Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Veterinary Pharmaceutical Manufacturing Market Research Report | ANZSIC C1842 | Feb 2015

Cash cows: Increasing demand from livestock farmers will help boost industry revenue

The Veterinary Pharmaceutical Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Industry Statistics & Market Size
Revenue
$485m
Annual Growth 10-15
-0.4%
Annual Growth 15-20
Add to Cart
Profit
Add to Cart
Employment
1,215
Businesses
49
Industry Analysis & Industry Trends

The Veterinary Pharmaceutical Manufacturing industry is a relatively small segment of the general Australian pharmaceutical sector. The industry is involved in the development and manufacture of animal health products including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food-producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). In 2012-13, the industry accounted for just 4.5% of the overall pharmaceutical sector.

Over the five years through 2014-15, the performance of the industry has been highly volatile, as it has contended with a number of external shocks... purchase to read more

Industry Report - Industry Key Buyers Chapter

Echoing the unprecedented degree of change currently occurring within the general pharmaceutical sector, the competitive landscape of the Veterinary Pharmaceutical Manufacturing industry has undergone significant change in the five years through 2014-15. Consolidation pressures continue to characterise the industry, and this has had implications for market share concentration trends.

Following Pfizer's 2009 acquisition of Wyeth Corporation and its subsidiary Fort Dodge Animal Health, the industry underwent a significant shake up. Fort Dodge's assets were split in Australia between Pfizer and Virbac, both already major players. This resulted in increased industry concentration... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Veterinary Pharmaceutical Manufacturing Industry?

This industry is mainly engaged in manufacturing drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use. These animal health products are targeted towards food-producing animals (cattle, pigs, poultry and sheep) and companion animals (dogs and cats).

Industry Products
ParasiticidesOther productsAntibiotics and related productsImmunotherapy products and vaccinesNutrition and metabolism productsDermatological preparationsMusculosketal system products
 
Industry Activities
ParasiticidesImmunotherapy product including vaccinesNutritional and metabolism productAntibioticsOther animal healthcare product


View Sample
Quote
Select Clients